Compare HTCR & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HTCR | SBFM |
|---|---|---|
| Founded | 2009 | 2006 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3M | 2.2M |
| IPO Year | 2022 | 2008 |
| Metric | HTCR | SBFM |
|---|---|---|
| Price | $1.69 | $2.84 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 13.7K | ★ 10.1M |
| Earning Date | 11-17-2026 | 11-16-2026 |
| Dividend Yield | ★ 200.00% | N/A |
| EPS Growth | ★ 414.29 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $30,407,229.00 | ★ $36,305,891.00 |
| Revenue This Year | $118.88 | $1.23 |
| Revenue Next Year | N/A | $22.44 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 39.19 | 4.11 |
| 52 Week Low | $1.25 | $0.13 |
| 52 Week High | $17.85 | $17.90 |
| Indicator | HTCR | SBFM |
|---|---|---|
| Relative Strength Index (RSI) | 29.87 | 70.00 |
| Support Level | $1.25 | $1.06 |
| Resistance Level | $2.16 | $3.05 |
| Average True Range (ATR) | 0.09 | 0.25 |
| MACD | 0.00 | 0.21 |
| Stochastic Oscillator | 11.63 | 76.05 |
HeartCore Enterprises Inc is a software development company providing solutions for digital transformation (DX). It develops, sells, and maintains CMS and CXM platforms using digital marketing technology, RPA, process mining solutions, myInvenio and Apromore, task mining solution CONTROLIO, and 3D-VR services including Matterport and VR360. The company also provides management consulting, education, services, and support to help customers succeed with the CXM Platform. It operates through two business units, the CX division for customer experience management and the DX division for digital transformation, which provides robotics process automation, process mining, and task mining. Its products include VR360, myInvenio, Apromore, and others, with maximum revenue from the United States.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.